Austin Neuromuscular Center

Austin Neuromuscular Center is a clinical neurology practice specializing in the diagnosis and treatment of neuromuscular disorders, including ALS and Charcot-Marie-Tooth disease. It is recognized as a Certified ALS Treatment Center of Excellence and provides multidisciplinary care, including neurophysiological testing, infusion therapy, physical and occupational therapy, genetic counseling, and orthotic services. The center also participates in clinical research, such as the Phase III PREMIER trial for PXT3003 in Charcot-Marie-Tooth disease type 1A, but is primarily a clinical care provider rather than a biotech, pharma, or platform company.